Stay updated on Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial

Sign up to get notified when there's something new on the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added. Revision: v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-18T19:37:54.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3; no user-facing content changes are indicated.
    Difference
    0.0%
    Check dated 2026-03-11T18:33:06.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    49 days ago
    Change Detected
    Summary
    The page shows a minor site maintenance update: addition of Revision: v3.4.2 and removal of the older funding-related note (Revision: v3.4.1); no changes to core study details, eligibility, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-11T09:56:06.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and updated the revision tag to v3.4.1, replacing the previous v3.4.0.
    Difference
    0.1%
    Check dated 2026-02-04T06:30:43.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    A glossary display option was added and several study metadata fields were updated (e.g., Results First Posted and Last Update Posted). The older estimated fields and No FEAR Act data were removed, and the site version updated to Revision: v3.4.0.
    Difference
    0.1%
    Check dated 2026-01-28T04:33:30.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    - Removed sponsor branding (Bristol-Myers Squibb / BMS) and access to key study documents/links (PDF; 'Helpful Links Provided by'). This reduces visibility of sponsor information and availability of official materials on the Study Details page.
    Difference
    18%
    Check dated 2026-01-21T04:30:41.000Z thumbnail image

Stay in the know with updates to Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page.